Pharma

Your Article Summary

See Latest Articles

Cytokinetics Presents Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
Cytokinetics, 09/16/09

Cytokinetics, Incorporated announced that data relating to two Phase IIa clinical trials evaluating omecamtiv mecarbil, one in stable heart failure patients and one in patients with ischemic cardiomyopathy and angina, were presented in three poster presentations at the 2009 Heart Failure Society of America Annual Meeting in Boston, Massachusetts.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
Sanofi-aventis, 12/16/09

A Clinical Review of Echinocandins in Pediatric Patients
Annals of Pharmacotherapy, 12/16/09

Second Pivotal Phase III Study of Gileads Darusentan for Resistant Hypertension Misses Primary Endpoints
Gilead, 12/15/09

 See all of Drug Trials